Join

2024 Clinical Inquiry (Research/EBP/QI)
CALL FOR ABSTRACTS

ASPAN 43rd Annual National Conference
April 14-18, 2024, Orlando, Florida

Submission Deadline for Abstract Submission for Consideration for Poster and/or Oral Presentation was October 15, 2023

ASPAN’s 43rd National Conference in Orlando, Florida, will feature abstracts/posters displayed in two categories: the Clinical Inquiry (Research/EBP/QI) category and the Celebrate Successful Perianesthesia Practices (CSPP) category. There are very specific guidelines and requirements for each grouping. To ensure you are submitting in the correct category, please read the requirements for a Celebrate Successful Perianesthesia Practices abstract submission prior to submitting your Clinical Inquiry (Research/EBP/QI) Abstract. It is the submitter’s responsibility to select the appropriate category (Research/EBP/QI or CSPP) and to meet the appropriate calendar deadline for submission.


The ASPAN Clinical Inquiry Committee provides active perianesthesia nurses with an opportunity to present previously completed, unreported, original research findings from studies pertaining to all phases of perianesthesia nursing. A choice of consideration for poster or oral and poster format may be selected for the 2024 National Conference presentations. Oral papers will be presented during the “Oral Research Presentations” session. Poster presenters are required to be in attendance to answer questions during grand rounds. A copy of the Institutional Review Board approval letter must be submitted for Research Category Abstracts. Those submitting oral and poster abstracts are given the opportunity to have their abstracts published in the August issue of the Journal of PeriAnesthesia Nursing (JoPAN). Past issues of JoPAN may be helpful for abstract development. Other helpful resources are available in the Clinical Inquiry section of ASPAN’s Web site. 

Carefully follow the guidelines for abstract submission below when submitting an abstract for anonymous peer review. Acceptance of abstracts is based on scientific merit and strict adherence to submission guidelines. All project contributors receive a participation certificate. 


Important Dates

  1. Submissions MUST be emailed by October 15, 2023. Any submissions received after this date will be returned and not reviewed.
  2. Your main contact will be notified of acceptance to either poster session or oral and poster presentation by January, 2024.
  3. A pdf or PowerPoint slide of your finished poster must be submitted to the National Office by March 25, 2024.

Required Information Form

  • Presenter(s) must be identified on the Required Information Form and at least one identified presenter must be a current ASPAN member.
  • The Main Contact listed on the Required Information Form will be the individual that ASPAN will contact with any questions, and also the individual who will be notified of acceptance.
  • Be sure to check off either Poster, or Oral and Poster preference.

Financial Relationship Disclosure

  • Complete a Financial Relationship Disclosure for the main contact.
  • Because ASPAN awards contact hours for viewing and evaluating the poster boards, a Financial Relationship Disclosure must be submitted for your Main Contact.

PDF or PowerPoint Slide of Poster

  • If accepted, submission of a pdf or PowerPoint slide of your final poster is required by March 25, 2024 to be emailed to ezeiger@aspan.org. This will be posted on the ASPAN website after conference along with your abstract and contact information.

Required Format for RESEARCH Abstracts:

(please include a copy of the IRB Approval Letter)

  • Title for the research presentation
  • Primary Investigator(s) name and credentials
  • Institution/Hospital affiliation for the research, city and state 
  • Co-investigator(s) name and credentials
  • Body of the abstract to include the following: 
    • Introduction
    • Identification of the Problem
    • Purpose of the Study
    • Methodology
    • Results
    • Discussion
    • Conclusion
    • Implications for perianesthesia nurses and future research
  • Sample of how Research Abstract should be formatted

Required Format for EVIDENCE-BASED PRACTICE Abstracts:

  • Title for the evidence-based practice presentation
  • Primary Investigator(s) name and credentials
  • Institution/Hospital affiliation, city and state
  • Co-investigator(s) name and credentials
  • Body of the abstract to include the following:
    • Introduction
    • Identification of the Problem
    • EBP Question/Purpose:  PICO question. Databases utilized.
    • Methods/Evidence
    • Significance of Findings/Outcomes
    • Implications for perianesthesia nurses and future research
  • Sample of how EBP Abstract should be formatted

Required Format for QI Abstracts:

  • Title for the QI presentation
  • Primary Investigator(s) name and credentials
  • Institution/Hospital affiliation, city and state 
  • Co-investigator(s) name and credentials 
  • Body of the abstract to include the following:
    • Introduction
    • Identification of the Problem
    • QI Questions/Purpose of the Study
    • Methods
    • Outcomes/Results
    • Discussion
    • Conclusion
    • Implications for perianesthesia nurses and future research
  • Sample of how QI Abstract should be formatted

Submitting your Abstract

  1. Complete the Clinical Inquiry (Research/EBP/QI) Abstract Required Information Form.
  2. Complete a  Financial Relationship Disclosure for the main contact.
  3. Be sure to indicate if you are submitting a Research, EBP, or QI abstract, and use the correct format for the type of abstract you are submitting.
  4. Use the following guidelines for formatting and submitting your abstract:
    1. Abstracts should be single-spaced. Please use a 12-point font. The following margins must be used:  top 1 inch; bottom 1 inch; left 1 inch; right 1 inch. Accuracy is critical.
    2. The title should be printed in Bold Letters, followed by the primary investigator’s name, credentials, and institution. You may list more than one primary investigator. 
    3. The primary investigator(s) must be clearly identified. The first name, last name, and credentials should be included. Institution, city and state should follow the primary investigator’s name. List co-investigators including their first name, last name and credentials. 
    4. Leave two spaces before the body of the abstract. The body must not exceed 350 words. The demographic information and topic headings do not count into the body word count.
    5. Submit two copies of the abstract:  one copy must be anonymous for peer review purposes and one copy must have complete identification, indicating the primary investigator(s) and all co-investigators. Include credentials. All information will be printed as submitted. 
    6. Submissions will only be accepted via email.  
    7. Email: Attach both copies of the abstract, the Required Information Form, and the Financial Relationship Disclosure, and email to Eileen Zeiger at the ASPAN National Office, ezeiger@aspan.org. Please be sure to include the words “Clinical Inquiry - Research/EBP/QI Abstract Submission” in the subject line of your email. Only acceptable formats for emailing are .doc or .docx. Abstracts submitted in .pdf format will not be accepted.
    8. Research submissions must include the IRB Approval letter. IRB letters may be in pdf format.
  5. After submitting your abstract via email, you will receive a return email confirming receipt. If you do not receive the confirmation email within 48 hours, please resubmit. 
  6. If your abstract is accepted for presentation, submit a pdf or PowerPoint slide of your final poster by March 25, 2024 to ezeiger@aspan.org.

The ASPAN Clinical Inquiry Committee looks forward to receiving your abstract via email by October 15, 2023. Email your submissions to ezeiger@aspan.org. Thank you in advance for your interest, participation and support in perianesthesia research.


Forms and Sample Abstracts

(all forms must be completed and emailed before the abstract will be reviewed)